Langerhans cell histiocytosis
1 paper
Trial sponsors
1 trialPhase 420 people
Shanghai Children's Medical Center
1 trialPhase 3200 people
1 trialPhase 3124 people
Masonic Cancer Center, University of Minnesota
2 trialsPhase 2/341 people
North American Consortium for Histiocytosis
1 trialPhase 2/31,400 people
Peking Union Medical College Hospital
2 trialsPhase 263 people
1 trialPhase 21,377 people
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
1 trialPhase 240 people
Latest
Zhonghua Xue Ye Xue Za Zhi
Immune microenvironment of Langerhans cell histiocytosis: from immune suppression to targeted therapy
ReviewImmune response